Articles > Popular publications > PR Newswire press releases > October-December 2004 > Tuesday, October 12

Article: PowderMed Initiates a Phase I Clinical Trial for a Novel Therapeutic Herpes Simplex Type 2 (HSV2) DNA Vaccine.

Article from:
PR Newswire
Article date:
October 12, 2004
Copyright

OXFORD, England, October 12 /PRNewswire/ -- Phase I clinical trial in patients of therapeutic DNA vaccine for the treatment of HSV2 commences at The Centre for Clinical Studies in Houston, Texas using PowderMed's novel DNA-on-Gold technology

PowderMed Ltd (PowderMed), a company focusing on the development of therapeutic DNA vaccines has announced that it has initiated a Phase I trial in patients of a novel therapeutic DNA vaccine for the treatment of Herpes Simplex Type 2 (HSV2). This therapeutic vaccine uses PowderMed's proprietary Particle Mediated Epidermal Delivery (PMED(TM)) technology to deliver a DNA plasmid coding for four HSV2 antigens.

The ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: PowderMed Launched in Spin Out of Powder Injection DNA ...
PR Newswire;  May 17, 2004 ;     700+ words ... ... therapeutic effect. PowderMed's lead preclinical ... and cancer, namely genital herpes, hepatitis B, genital ... Company, Dr Dix said: "PowderMed's technology is clinically ... diseases and cancer. PowderMed has five preclinical lead programmes targeting genital herpes, hepatitis B, ...

Article: PowderMed Manufactures a Vaccine Against H5N1 (Avian ...
Business Wire;  August 1, 2005 ;     700+ words ... ... www.powdermed.com PowderMed is a private immunotherapeutic ... the pandemic threat. PowderMed also has a product for the treatment of genital herpes in Phase I trials, and ... Glaxo SmithKline). PowderMed vaccines are delivered ...

Article: PowderMed to Conduct U.S. Clinical Trial of DNA-Based ...
Business Wire;  October 2, 2006 ;     700+ words ... ... strain. About PowderMed PowderMed is a private immunotherapeutic ... the pandemic threat. PowderMed also has a product for the treatment of genital herpes in Phase I trials, and ... Glaxo SmithKline). PowderMed vaccines are delivered ...

Article: Ludwig Institute for Cancer Research and PowderMed ...
PR Newswire;  September 17, 2004 ;     700+ words ... ... PowderMed Ltd - http://www.powdermed.com/ PowderMed Ltd, a leader in the development ... chronic viral diseases and cancer. PowderMed has five preclinical lead programmes targeting genital herpes, hepatitis B, genital warts ...

Article: Chiron Spins Powder Injection Technology Into PowderMed ...
BIOWORLD Today;  November 3, 2009 ;     700+ words ... ... GlaxoSmithKline plc, of London. PowderMed has rights to develop vaccines ... undisclosed minority stake in PowderMed and has an option on U.S ... a DNA vaccine for treating genital herpes. Other terms were not revealed ... spinout and will be CEO of PowderMed. He told BioWorld Today ...

Article: CHIRON SPINS POWDER INJECTION TECHNOLOGY INTO POWDERMED ...
BIOWORLD Today;  May 18, 2004 ;     700+ words ... ... GlaxoSmithKline plc, of London. PowderMed has rights to develop vaccines ... undisclosed minority stake in PowderMed and has an option on U.S ... a DNA vaccine for treating genital herpes. Other terms were not revealed ... spinout and will be CEO of PowderMed. He told BioWorld Today ...

Article: Positive Outcome of Phase I DNA Influenza Study; PowderMed ...
PR Newswire;  November 18, 2004 ;     700+ words ... ... unit of Chiron Corporation . PowderMed has acquired the rights to ... viral diseases and cancer. PowderMed has a proprietary therapeutic vaccine for the treatment of genital herpes in Phase I trials and also ... northbankcommunications.com. PowderMed Ltd: Dr Clive Dix, Tel ...

Article: PowderMed's DNA-Based Flu Vaccine Shows Cross-Protective ...
Business Wire;  December 19, 2005 ;     700+ words ... ... About PowderMed, Ltd PowderMed is a private immunotherapeutic ... the pandemic threat. PowderMed also has a product for the treatment of genital herpes in Phase I trials, and ... Glaxo SmithKline). PowderMed vaccines are delivered ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives